TNF and COVID-19: This supports the hypothesis that SARS-CoV-2 drives monocytes and macrophages to induce host immunoparalysis, which, potentially translates into less severe symptoms, reduced MHC class 2 expression and TNF production as cells become refractory to chronic stimulation for the benefit of COVID-19 progression [21].